29 research outputs found

    Consistent improvement with eculizumab across muscle groups in myasthenia gravis

    Get PDF

    Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

    Get PDF

    Notes for genera: basal clades of Fungi (including Aphelidiomycota, Basidiobolomycota, Blastocladiomycota, Calcarisporiellomycota, Caulochytriomycota, Chytridiomycota, Entomophthoromycota, Glomeromycota, Kickxellomycota, Monoblepharomycota, Mortierellomycota, Mucoromycota, Neocallimastigomycota, Olpidiomycota, Rozellomycota and Zoopagomycota)

    Get PDF
    Compared to the higher fungi (Dikarya), taxonomic and evolutionary studies on the basal clades of fungi are fewer in number. Thus, the generic boundaries and higher ranks in the basal clades of fungi are poorly known. Recent DNA based taxonomic studies have provided reliable and accurate information. It is therefore necessary to compile all available information since basal clades genera lack updated checklists or outlines. Recently, Tedersoo et al. (MycoKeys 13:1--20, 2016) accepted Aphelidiomycota and Rozellomycota in Fungal clade. Thus, we regard both these phyla as members in Kingdom Fungi. We accept 16 phyla in basal clades viz. Aphelidiomycota, Basidiobolomycota, Blastocladiomycota, Calcarisporiellomycota, Caulochytriomycota, Chytridiomycota, Entomophthoromycota, Glomeromycota, Kickxellomycota, Monoblepharomycota, Mortierellomycota, Mucoromycota, Neocallimastigomycota, Olpidiomycota, Rozellomycota and Zoopagomycota. Thus, 611 genera in 153 families, 43 orders and 18 classes are provided with details of classification, synonyms, life modes, distribution, recent literature and genomic data. Moreover, Catenariaceae Couch is proposed to be conserved, Cladochytriales Mozl.-Standr. is emended and the family Nephridiophagaceae is introduced

    A exposição ocupacional ao mercúrio metálico no módulo odontológico de uma unidade básica de saúde localizada na cidade de São Paulo Occupational exposure to metallic mercury in the dentist's office of a public primary health care clinic in the city of São Paulo

    No full text
    Este artigo visa discutir a exposição ocupacional ao mercúrio metálico de dentistas e assistentes, enfocando a avaliação biológica, os efeitos na saúde e a avaliação ambiental. Os métodos utilizados foram visitas à unidade, avaliação ambiental, mapas de riscos, dosagens de mercúrio urinário e avaliação da saúde. Os resultados referentes ao ambiente e processos de trabalho mostraram: 1) as concentrações de vapor de mercúrio que impregnavam o revestimento ou tubulações de encanamentos variaram entre 0,001 e 0,051 mg/m3 de ar; 2) exposição ocupacional, havendo 62,5% dos trabalhadores com dosagens de mercúrio urinário entre 10 e 49µg/l e 37,5% abaixo de 10 µg/l em 1994. Estes trabalhadores estiveram expostos desde 1992, sendo suas dosagens de mercúrio urinário de 1992 inferiores às atuais; 3) vazamento de mercúrio e amalgamação inadequada, em função de um amalgamador defeituoso; 4) a necessidade de usar um pedaço de camurça para obter um amalgama homogêneo e remover o excesso de mercúrio; 5) a existência de riscos combinados e simultâneos na situação de trabalho. Os resultados concernentes à saúde mostraram: 1) a prevalência de sintomas relativos ao Sistema Nervoso Central; 2)sinais do quadro neurológico e/ou do quadro psíquico, mas não do quadro gastrintestinal; 3) intoxicações crônicas de leves a moderadas em 62,5% dos trabalhadores.<br>This paper discusses occupational exposure to metallic mercury among dentists and dental assistants, focusing on biological evaluation, effects on heaith, and environmental evaluation. Methods included visits to the clinic, hazard maps, urinary and environmental mercury measurements, and evaluation of health status. Results for the environment and work processes showed that mercury vapor concentrations impregnating surfaces and piping varied from 0.001 to 0.051 mg/m3 in air; occupational exposure with 62.5% of health workers having HgU ranging from 10 to 49 mg/l and 37.5% having HgU below 10 mg/l in 1994, while workers' previous measures (from 1992) were lower in every single case; an outflow of mercury and inadequate amalgamation due to a faulty amalgamator, the need for using a piece of chamois to obtain a homogeneous amalgam and remove excess mercury; the existence of combined hazards in the environment, and that all workers had been exposed since 1992. Results for workers' health showed a prevalence of symptoms from lesions to the central nervous system; central nervous system signs; and that mild-to-moderate chronic poisoning was found in 62.5% of workers

    Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives

    Get PDF
    The definition of a biomarker provided by the World Health Organization is any substance, structure, or process that can be measured in the body, or its products and influence, or predict the incidence or outcome of disease. Currently, the lack of prognosis and progression markers for chronic Chagas disease has posed limitations for testing new drugs to treat this neglected disease. Several molecules and techniques to detect biomarkers in Trypanosoma cruzi-infected patients have been proposed to assess whether specific treatment with benznidazole or nifurtimox is effective. Isolated proteins or protein groups from different T. cruzi stages and parasite-derived glycoproteins and synthetic neoglycoconjugates have been demonstrated to be useful for this purpose, as have nucleic acid amplification techniques. The amplification of T. cruzi DNA using the real-time polymerase chain reaction method is the leading test for assessing responses to treatment in a short period of time. Biochemical biomarkers have been tested early after specific treatment. Cytokines and surface markers represent promising molecules for the characterisation of host cellular responses, but need to be further assessed.RICET RD12/0018/0010. RICET RD12/0018/0021. AGAUR 2014SGR26. Plan Nacional de I+D+I SAF2012-35777. Plan Nacional de I+D+I SAF2013-48527-R. NIMHD/NIH 2G12MD007592. Financial support: CRESIB and IPBLN research members were partially supported by the RICET (RD12/0018/0010, RD12/0018/0021), M-JP and JG received research funds from AGAUR (2014SGR26) and Fundación Mundo Sano, M-CT and M-CL were supported by Plan Nacional de I+D+I (MINECO-Spain) (SAF2012-35777, SAF2013-48527-R and FEDER), ICA was partially supported by NIMHD/NIH (2G12MD007592). Financial support: CRESIB and IPBLN research members were partially supported by the RICET (RD12/0018/0010, RD12/0018/0021), M-JP and JG received research funds from AGAUR (2014SGR26) and Fundación Mundo Sano, M-CT and M-CL were supported by Plan Nacional de I+D+I (MINECO-Spain) (SAF2012-35777, SAF2013-48527-R and FEDER), ICA was partially supported by NIMHD/NIH (2G12MD007592).Peer reviewe
    corecore